Mitotic index does not predict prognosis in stage IA non-small cell lung cancer

Lung Cancer

Volumn 38, Issue 2, 2002, Pages 163-167

  Daniels, J M A ^a   Eerenberg, J P ^a   Rijna, H ^a   Kummer, J A ^b   Broeckaert, M A M ^b   Paul, M A ^a   van Diest, P J ^b   van Mourik, J C ^a  

^a Location Alkmaar   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lung cancer; Mitosis; Mitotic index; Non small cell lung cancer; Prognostic factor; Proliferation; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; EVALUATION; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MITOSIS INDEX; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL;

EID: 0036837801     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00215-5     Document Type: Article

References (29)

1. Revisions in the international system for staging lung cancer
2. Proliferation markers in tumours: interpretation and clinical value
3. The value of morphometry to classic prognosticators in breast cancer
4. Prognostic indicators in breast cancer-morphometric methods
5. Prognostic scoring using cytomorphometry and lymph node status of patients with breast carcinoma
6. Predicting breast cancer recurrence
7. Reproducibility of mitosis counting in 2469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project
8. The morphometric multivariate prognostic index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients
9. The mitotic index in the prognosis of non-small cell lung cancer
10. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer
11. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer
12. Apoptosis and mitosis as prognostic factors in pathologically staged N1 non-small cell lung cancer
13. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0M0 non-small cell lung cancer
14. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter
15. Most peripheral, node-negative non-small cell lung cancers have low proliferative rates and no intra-tumoral an peritumoral blood and lymphatic vessel invasion: rationale for treatment with wedge resection alone
16. Nonparametric estimation from incomplete observations
17. Evaluation of survival data and two new rank order statistics arising in its consideration
18. Regression models and life tables
19. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer
20. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis
21. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis
22. Micrometastases in non-small cell lung cancer
23. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
24. Results after surgery in stage I bronchogenic carcinoma
25. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer
26. Stage I non-small cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
27. Correlation of tumor size and survival in patients with stage Ia non-small cell lung cancer
28. Prognostic factors in patients with resected stage I NSCLC: a report from the Lung Cancer Study Group
29. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease